Deutsche Bank Ag\ Sangamo Therapeutics, Inc Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $40,139 - $131,887	-95,571 Reduced 60.44%	62,549 $41,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $28,737 - $60,348	95,792 Added 153.69%	158,120 $85,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $56,659 - $88,818	-51,045 Reduced 45.02%	62,328 $81,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $50,060 - $110,676	30,157 Added 36.24%	113,373 $199,000
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $82,188 - $150,431	29,671 Added 55.41%	83,216 $261,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $47,572 - $71,190	-11,141 Reduced 17.22%	53,545 $262,000
Q2 2022 Aug 11, 2022	SELL	$3.28 - $6.21 $38,887 - $73,625	-11,856 Reduced 15.49%	64,686 $267,000
Q1 2022 May 13, 2022	SELL	$5.23 - $7.82 $38,273 - $57,226	-7,318 Reduced 8.73%	76,542 $445,000
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $28,955 - $43,572	3,972 Added 4.97%	83,860 $629,000
Q3 2021 Nov 04, 2021	SELL	$9.01 - $12.01 $53,249 - $70,979	-5,910 Reduced 6.89%	79,888 $719,000
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $22,546 - $28,022	-2,217 Reduced 2.52%	85,798 $1.03 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $1.89 Million - $2.96 Million	-173,449 Reduced 66.34%	88,015 $1.1 Million
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $528,759 - $1.04 Million	57,287 Added 28.06%	261,464 $4.08 Million
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $2.32 Million - $3.08 Million	-247,078 Reduced 54.75%	204,177 $1.93 Million
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $2.11 Million - $4.02 Million	339,409 Added 303.46%	451,255 $4.04 Million
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $2.79 Million - $4.88 Million	-551,650 Reduced 83.14%	111,846 $713,000
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $1.92 Million - $2.8 Million	-239,286 Reduced 26.51%	663,496 $5.55 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $5.02 Million - $6.77 Million	-554,190 Reduced 38.04%	902,782 $8.17 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $4.21 Million - $6.27 Million	481,525 Added 49.36%	1,456,972 $15.7 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $6.08 Million - $10.1 Million	787,569 Added 419.19%	975,447 $9.3 Million
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $6.93 Million - $12.1 Million	-728,952 Reduced 79.51%	187,878 $2.16 Million
Q3 2018 Dec 21, 2021	BUY	$13.05 - $19.05 $4.08 Million - $5.96 Million	312,783 Added 51.78%	916,830 $15.5 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $2.26 Million - $3.29 Million	-172,884 Reduced 22.25%	604,047 $10.2 Million
Q2 2018 Apr 21, 2020	BUY	$13.9 - $19.8 $772,381 - $1.1 Million	55,567 Added 7.7%	776,931 $11 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $3.12 Million - $4.44 Million	224,137 Added 45.08%	721,364 $10.2 Million
Q1 2018 Oct 18, 2019	BUY	$16.7 - $26.35 $2.19 Million - $3.46 Million	131,229 Added 35.86%	497,227 $9.45 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $2.15 Million - $3.39 Million	128,647 Added 54.2%	365,998 $6.95 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $9.08 Million - $13.6 Million	-782,985 Reduced 76.74%	237,351 $3.89 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $8.57 Million - $15.3 Million	1,020,336	1,020,336 $15.3 Million

Others Institutions Holding SGMO

# of Institutions

133

Shares Held

86.3M

Call Options Held

35.9K

Put Options Held

156K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$17.5 Million
0.04% of portfolio
Armistice Capital, LLC New York, NY

14.1M
Shares

$12.2 Million
0.07% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$10.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$4.09 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.56M
Shares

$3.97 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account